ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.496,79
0,12%
S&P 500
5.235,48
-0,60%
Dow Jones
38.111,48
-0,86%
Euro vs US Dollar
1,08191
-0,11%
Bitcoin
68.629,09
0,39%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Humanigen Inc (HGEN)

  7. Humanigen Inc (HGEN) News

HGEN

Humanigen (HGEN)

Humanigen Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HGEN
DatumZeitQuelleÜberschriftSymbolFirma
08/01/202423h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HGENHumanigen Inc
14/09/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HGENHumanigen Inc
15/05/202312h36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HGENHumanigen Inc
25/04/202322h06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:HGENHumanigen Inc
19/04/202312h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
06/04/202322h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
13/03/202311h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
01/02/202319h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HGENHumanigen Inc
22/12/202223h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
14/11/202222h44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HGENHumanigen Inc
14/11/202222h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
21/10/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
19/10/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
14/10/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
12/10/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
07/10/202211h53PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
06/10/202223h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
30/09/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
28/09/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
23/09/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
21/09/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
16/09/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
14/09/202212h15TipRanksH.C. Wainwright Remains a Hold on Humanigen (HGEN)NASDAQ:HGENHumanigen Inc
14/09/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
09/09/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
07/09/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Humanigen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 25, 2022 - (NASDAQ: HGEN)NASDAQ:HGENHumanigen Inc
02/09/202222h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
02/09/202211h45PR Newswire (US)HGEN SHAREHOLDER ALERT: Jakubowitz Law Reminds Humanigen Shareholders of a Lead Plaintiff Deadline of October 25, 2022NASDAQ:HGENHumanigen Inc
26/08/202222h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HGENHumanigen Inc
15/08/202212h16TipRanksHumanigen (HGEN) Gets a Hold from H.C. WainwrightNASDAQ:HGENHumanigen Inc
 Showing the most relevant articles for your search:NASDAQ:HGEN

Kürzlich von Ihnen besucht

BIT
UC7KB1
Unicredit Bank
GATE
QRDOETH
Qredo Token
EU
E572T
E572T
NASDAQ
FFLFPX
Energy Select Portfolio ...
NASDAQ
CTNT
Cheetah Net Supply Chain...
NASDAQI
FN10GI
First North Technology GI
BIT
UC914S
Unicredit Bank
USOTC
GSTK
Growth Stalk (PK)
LSE
HITC
H S&p Ind Tech
TG
7RG0
Regulus Therapeutics
BIT
UC8YK2
Unicredit Bank
TG
8AGA
AG Mortgage Investment
LSE
0K17
Microvision
TG
OCZA
Catalana Occidente
NASDAQ
FJWWTX
Equity Allocation Etf Mo...
USOTC
IMSMF
Italmobiliare (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten